The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) just released the report on the formal risk assessment for furanylfentanyl.
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl),
carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017.
On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 15 November 2017,
the Council decided that furanylfentanyl should be subject to control measures across the Member States.
The entire risk assessment report can be downloaded in pdf format